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The aim of this study was to evaluate the prevalence of chronic pain (CP) and the relationship be-
tween CP, especially headache adjusted for CP at other sites, and health-related quality of life 
(HRQoL) in middle-aged Japanese residents. We examined the prevalence of CP (defined as pain 
persisting for 3 months or more) and HRQoL (SF-36) in 1117 middle-aged residents of Japan. We 
assessed the eight dimensions of health status and the 3 component SF-36 summary score to eva-
luate HRQoL. The prevalence of CP was 15.3% among men and 15.1% among women. Multiple li-
near regression analysis demonstrated that lumbar pain (p < 0.001, β = −0.132), knee pain (p < 
0.001, β = −0.115), foot pain (p = 0.042, β = −0.065), and age (p < 0.001, β = −0.154) were indepen-
dently correlated with a lower physical component score (PCS). Older age (p < 0.001, β = 0.221) 
showed a significant positive correlation with mental component score (MCS), while neck/shoul- 
der pain (p < 0.01, β = −0.096), knee pain (p < 0.001, β = −0.109), upper limb pain (p < 0.01, β = 
−0.098), and lumbar pain (p = 0.022, β = −0.077) all showed a significant negative correlation with 
MCS. The presence of chronic headache (p = 0.011, β = −0.082) was the only factor significantly 
correlated with a lower role component score (RCS). We identified a negative correlation between 
chronic headache and RCS, unlike the relation between musculoskeletal pain and PCS or MCS, 
suggesting that RCS was an independently influenced by CP differently from PCS or MCS in Japa-
nese residents. 








The International Association for the Study of Pain (IASP) defines pain as an unpleasant sensory and emotional 
experience associated with actual or potential tissue damage, or described in terms of such damage [1]. In addi-
tion, the IASP defines chronic pain (CP) as pain without an apparent biological cause that persists beyond the 
normal time for tissue healing (usually 3 months) [2].  
Some of the previous studies have been hospital-based [3] or focused on the elderly persons [4], and few stu-
dies have investigated CP in the general Japanese population. In a telephone survey study, among the general 
population in European countries and Israel shows a variation in prevalence of CP that ranges from 12% to 30% 
depending on the geographical area and age [5]. Previous survey shows that 9% to 28% of the Japanese popula-
tion have CP, and that it is less frequent in people under 40 years old than in other age groups, whereas it ap-
pears to be higher in the 41 - 60 age group than in the others [6] [7]. Also there is a higher prevalence among 
elderly persons and in women [6]-[8]. A study performed in Japan reports aging as part of reason for increase of 
persons suffering from CP, however, it still remains unclear [9]. CP is usually musculoskeletal pain, such as 
lumbar pain, shoulder pain, or knee pain [6]-[8]. It is common for people with CP to be on long-term therapy 
and to be dissatisfied with their current treatment [10].  
CP causes deterioration of HRQoL because it not only affects the physical condition and ability to function, 
but also the person’s mental health and daily activities [7], which can lead to exacerbation of symptoms. CP re-
stricts the ability to work and is responsible for substantial health care costs, resulting in it being a major public 
health problem worldwide [5]. Considering that the health effects of CP are multi-dimensional, it is important to 
elucidate the involvement of physical, mental, and social factors, as well as how role factors are related to CP. 
Among the various body sites affected by CP, headache is reported to cause marked impairment of daily ac-
tivities, such as family and social activities [11]. Chronic headache results in substantially greater disability than 
other types of headache [12], and is often combined with other chronic pain disorders [13]. To measure the disa-
bility caused by headache itself, we need to adjust for the impact of chronic pain at other sites. Therefore, we 
examine the prevalence of both headache and CP at other sites, as well as the impact on HRQoL, in middle- 
aged Japanese residents. 
2. Methods 
2.1. Subjects and Methods 
We performed this study from October to December 2012. The target population was all of the middle-aged 
persons legally residing in the two elementary school districts in a rural area (Shika, Isikawa prefecture). This 
study was supported by the Shika Municipal Government, which provided a list of all residents aged 40 to 65 
years in this area. The eligible population was 1291 persons and almost all of them were Japanese citizens. 
We provided self-administered questionnaire to the residents. After they filled in the answers, participants were 
asked to return the questionnaires in sealed envelopes to members of the health promotion team employed by 
Shika Municipal Government. 
The self-administered questionnaire was designed to obtain demographic data such as the age, gender, height 
and weight, as well as self-reported information on medical conditions such as cerebrovascular disease, cardi-
ovascular disease, hypertension, dyslipidemia, diabetes mellitus, history of fracture over 10 years, osteoarthritis, 
depression, osteoporosis, insomnia, rheumatoid arthritis, CP at up to 3 sites, and HRQoL. 
We asked the subjects to rate the severity of CP on a 10-point scale (0 = no pain to 10 = most severe pain ever 
experienced). We defined CP as pain persisting for 3 months or longer (in agreement with the IASP) at a severi-
ty of more than 5 so that we could compare our data with other surveys performed in Europe and Japan [5] [6]. 
We asked about the presence of pain affecting the head, neck, shoulder, upper limb, back, lumbar, hip, knee, 
foot, chest, and abdomen. We classified the site of pain as follows: head, neck/shoulder, upper limb, lumbar re-
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gion, hip, knee, foot, and other (including back, hip, chest, and abdomen). 
To measure HRQoL, we used the SF-36, Japanese version 2. The SF-36 is used worldwide to measure 
HRQoL, especially in general populations. It has been translated into Japanese and validated for use in Japan 
[14]. SF-36 measures eight dimensions of health over four weeks, which are physical functioning (PF), role 
physical (RP), bodily pain (BP), general health (GH), vitality (VT), social function (SF), role emotional (RE), 
and mental health (MH). We used a norm-based scoring (NBS) system, in which all scores were converted to 
the values relative to the Japanese population (mean = 50 and standard deviation = 10 with a normal distribution; 
higher scores indicate better HRQoL) [15]. These eight scores were further summarized into three component 
summary scores, which were the physical component summary (PCS), mental component summary (MCS), and 
role component summary (RCS). The factor structures of SF-36 reported in Japan [16], China [17] [18], Taiwan 
[19], and Singapore [20] are considered to differ from those found in western countries [21]. A previous study 
on validation of component models supported a three-component model as superior to a two-component model 
in Japan [22]. A three-component model was demonstrated to provide “purer” factor-loading patterns in the 
physical and mental components, with the mental component showing greater improvement [22]. Therefore, we 
employed a three-component model in this study. 
2.2. Statistics 
We used the unpaired t-test and analysis of variance (ANOVA) for continuous data. The chi-square test was 
employed for categorical data, except when the expected number of cells was less than 5 in which case we used 
Fisher’s exact test. We used analysis of covariance (ANCOVA) for continuous data adjusted for age and gender. 
Multiple linear regression analysis was performed with a forward stepwise approach to estimate the impact of 
each variable on the component summary scores. The independent variables assessed included the age, gender 
(male 0, female 1), and each site of pain (no pain 0, with pain 1). All tests were 2-tailed, with differences re-
ported as significant at p < 0.05. Analyses were conducted using IBM SPSS Statistics version19 for Windows. 
2.3. Study Protocol Approval and Consent 
This study was conducted with the approval of the ethics review board of Kanazawa University (Kanazawa, Ja-
pan). All participants provided written informed consent by signing a form that described the purpose and pro-
cedures of the study, the potential risks and benefits associated with participation, the strictly voluntary nature of 
participation, the right to withdraw from the study without prejudice or penalty, and the guaranteed confidential-
ity and security of personal data. 
3. Results 
We excluded persons who did not give consent (n = 111), who could not be contacted (n = 52), and who were 
hospitalized or institutionalized (n = 11) from the 1291 residents, and obtained responses from 1117 people 
(86.0%; 556 men and 561 women, mean age: 54.7 ± 7.73 in male, 54.7 ± 7.66 in female). 
The prevalence of CP was 15.3% among men and 15.1% among women. In the male subjects, the site of pain 
(in decreasing order) was neck/shoulder pain in 6.86%, lumbar pain in 6.69%, foot pain in 3.43%, knee pain in 
2.88%, upper limb pain in 1.98%, and headache in 0.899%, while the site of pain in the female subjects was 
neck/shoulder pain in 7.16%, lumbar pain in 5.92%, knee pain in 3.58%, foot pain in 2.85%, upper limb pain in 
1.96%, and headache in 1.43%. There was one site of CP in 8.76% of male subjects and 7.94% of female sub-
jects, two sites in 4.20% and 4.69%, and three sites in 2.92% and 2.71% (Table 1).  
While VT, MH, and MCS were significantly higher, PCS was lower in the older subjects compared with the 
younger subjects among both males and females. PF was significantly lower in older subjects compared with 
younger subjects among females only (Table 2).  
ANCOVA with covariates of age and gender showed that PF, RP, BP, GH, VT, SF, RE, MH, PCS, and MCS 
were all significantly lower in the subjects with CP compared to those without CP. Only RCS showed no signif-
icant difference between subjects with and without CP (Table 3).  
To evaluate the impact of pain at different sites on HRQoL, we performed stratified analysis by pain site. The 
subjects with CP affecting the neck/shoulder, lumbar, knee, foot, and other sites had a significantly lower PCS 
than those without CP. In subjects with CP at all sites, MCS was significantly lower than in those without CP. In 
subjects with chronic headache, RCS was significantly lower than in those without CP (Table 4). 
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Table 1. Characteristics of the participants (N = 1117). 
Gender Male (n = 556) Female (n = 561) P value 
Age: mean (SD) 54.7 (7.73) 54.7 (7.66) 0.340 
Height (cm): mean (SD) 168.8 (6.14) 155.4 (5.49) 0.018 
Weight (kg): mean (SD) 67.8 (10.4) 54.4 (8.01) <0.001 
BMI: mean (SD) 23.8 (3.12) 22.6 (3.25) 0.246 
Diseases    
Cerebrovascular disease (%) 1.80 0.535 0.055 
Cardiovascular disease (%) 2.70 1.60 0.208 
Hypertension (%) 22.5 19.3 0.184 
Dyslipidemia (%) 10.4 16.4 <0.01 
Diabetes mellitus (%) 10.3 5.35 <0.01 
Fracture within 10 years (%) 4.86 3.39 0.217 
Osteoarthritis (%) 1.80 3.39 0.095 
Depression (%) 1.62 1.96 0.666 
Osteoporosis (%) 0.540 2.14 0.034 
Insomnia (%) 1.44 1.60 0.821 
Rheumatoid arthritis (%) 0.719 0.891 1.000 
Prevalence of pain    
Any (%) 15.3 15.1 0.919 
Head (%) 0.899 1.43 0.412 
Upper-limb (%) 1.98 1.96 0.980 
Neck/Shoulder (%) 6.86 7.16 0.846 
Lumbar (%) 6.69 5.92 0.600 
Knee (%) 2.88 3.58 0.508 
Foot (%) 3.43 2.85 0.580 
Others (%) 2.89 2.32 0.553 
Number of chronic pain site    
One site (%) 8.76 7.94 0.935 
Two sites (%) 4.20 4.69  
Three sites (%) 2.92 2.71  
SF-36 score    
PF: mean (SD) 49.9 (11.0) 49.5 (9.97) 0.306 
RP: mean (SD) 51.2 (9.22) 50.6 (9.29) 0.397 
BP: mean (SD) 49.9 (10.7) 50.3 (10.2) 0.536 
GH: mean (SD) 48.0 (9.04) 48.4 (9.24) 0.481 
VT: mean (SD) 50.3 (10.2) 50.1 (10.1) 0.907 
SF: mean (SD) 51.5 (9.23) 50.7 (9.56) 0.157 
RE: mean (SD) 51.8 (8.93) 50.7 (9.34) 0.026 
MH: mean (SD) 50.3 (9.31) 50.3 (9.52) 0.191 
PCS: mean (SD) 48.5 (10.6) 49.0 (9.96) 0.684 
MCS: mean (SD) 49.1 (9.74) 49.6 (9.80) 0.659 
RCS: mean (SD) 53.0 (10.1) 51.8 (10.1) 0.376 
SD: Standard Deviation; PF: Physical Functioning; RP: Role Physical; BP: Bodily Pain; GH: General Health; VT: Vitality; SF: Social Function; RE: 
Role Emotional; MH: Mental Health; PCS: Physical Component Summary; MCS: Mental Component Summary; RCS: Role Component Summary; 
Others include chest, abdomen, hip, and back pain. We used the unpaired t-test for continuous data and the χ2 test for categorical data. 
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Table 2. SF-36 scores of subjects in each age group. 
 
Male Female 
40 - 49 50 - 59 60 - 65 
P value 
40 - 49 50 - 59 60 - 65 
P value 
N Mean SD N Mean SD N Mean SD N Mean SD N Mean SD N Mean SD 
PF 136 50.3 (12.9) 164 50.8 (8.23) 179 48.9 (11.5) 0.272 140 51.5 (8.75) 195 49.6 (8.95) 178 47.9 (11.6) <0.01 
RP 135 52.0 (8.93) 163 51.1 (8.24) 179 50.6 (10.2) 0.410 141 51.8 (8.79) 193 50.8 (8.90) 177 49.4 (9.98) 0.061 
BP 136 49.4 (10.8) 164 50.3 (11.0) 180 49.8 (10.5) 0.767 142 50.3 (9.42) 195 50.1 (10.7) 178 50.6 (10.3) 0.899 
GH 136 48.2 (8.38) 164 47.2 (9.33) 178 48.6 (9.25) 0.311 141 48.8 (8.81) 193 47.7 (9.77) 177 48.8 (8.97) 0.447 
VT 136 48.4 (10.2) 164 48.9 (9.80) 177 53.1 (9.91) <0.001 141 47.6 (9.80) 194 49.4 (10.2) 176 53.0 (9.75) <0.001 
SF 136 51.4 (8.65) 163 51.2 (8.86) 180 51.8 (10.0) 0.858 142 49.5 (10.8) 193 50.7 (9.68) 178 51.5 (8.22) 0.182 
RE 135 52.5 (8.27) 162 51.2 (8.96) 179 51.8 (9.37) 0.439 141 50.9 (9.51) 193 50.7 (9.34) 176 50.6 (9.27) 0.955 
MH 136 48.6 (8.88) 164 49.3 (9.48) 177 52.5 (9.09) <0.001 141 48.4 (10.2) 192 50.2 (9.18) 176 51.9 (9.04) <0.01 
PCS 134 49.7 (12.2) 161 49.6 (8.14) 176 46.7 (11.1) 0.018 140 51.7 (8.69) 188 48.9 (9.39) 173 47.0 (11.0) <0.001 
MCS 134 47.0 (9.39) 161 47.6 (9.72) 176 52.0 (9.36) <0.001 140 47.0 (9.54) 188 48.9 (10.3) 173 52.4 (8.74) <0.001 
RCS 134 53.9 (9.26) 161 52.5 (10.1) 176 52.8 (10.7) 0.439 140 51.6 (11.4) 188 52.3 (9.63) 173 51.4 (9.59) 0.676 
SD: Standard Deviation; PF: Physical Functioning; RP: Role Physical; BP: Bodily Pain; GH: General Health; VT: Vitality; SF: Social Function; RE: 
Role Emotional; MH: Mental Health; PCS: Physical Component Summary; MCS: Mental Component Summary; RCS: Role Component Summary; 
ANOVA was employed for categorical data. 
 
Table 3. SF-36 scores of participants with or without chronic pain. 
 
With chronic pain Without chronic pain 
P value 
N Mean SD N Mean SD 
PF 150 44.9 12.4 831 50.6 9.72 <0.001 
RP 149 45.4 12.6 828 51.8 8.17 <0.001 
BP 150 38.8 9.43 834 52.2 9.22 <0.001 
GH 150 42.2 8.89 828 49.3 8.79 <0.001 
VT 151 43.0 9.72 827 51.6 9.64 <0.001 
SF 150 47.9 11.2 832 51.6 8.91 <0.001 
RE 148 47.1 11.8 827 51.9 8.43 <0.001 
MH 150 45.4 9.68 826 51.2 9.08 <0.001 
PCS 145 41.7 11.9 817 50.1 9.38 <0.001 
MCS 145 42.7 9.83 817 50.5 9.27 <0.001 
RCS 145 52.5 13.4 817 52.3 9.48 0.838 
SD: Standard Deviation; PF: Physical Functioning; RP: Role Physical; BP: Bodily Pain; GH: General Health; VT: Vitality; SF: Social Function; RE: 
Role Emotional; MH: Mental Health; PCS: Physical Component Summary; MCS: Mental Component Summary; RCS: Role Component Summary; 
ANCOVA was done with adjustment for age and gender. 
 
Table 5 shows the results of multiple linear regression analysis with a forward stepwise approach to select 
independent variables for the three component summary scores. In this analysis, the independent variables in-
cluded gender, age, and the site of pain. A lower PCS was independently correlated with CP at other sites (p < 
0.001, β = −0.172), lumbar CP (p < 0.001, β = −0.132), age (p < 0.001, β = −0.154), knee CP (p < 0.001, β = 
−0.115), and foot CP (p = 0.042, β = −0.065). Older age (p < 0.001, β = 0.221) showed a significant positive 
correlation with MCS, while neck/shoulder CP (p < 0.01, β = −0.096), CP at other sites (p < 0.001, β = −0.108), 
knee CP (p < 0.001, β = −0.109), upper limb CP (p < 0.01, β = −0.098), and lumbar CP (p = 0.022, β = −0.077) 
all showed a significant negative correlation with MCS. Chronic headache (p = 0.011, β = −0.082) only showed 
a significant correlation with a lower RCS (Table 5). 
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Table 4. SF-36 component summary scores for subjects with or without chronic pain at different sites. 
Chronic pain site  N 
PCS MCS RCS 
Mean SD P value Mean SD P value Mean SD P value 
Head (−) 962 48.8 10.3 0.171 49.4 9.77 0.013 52.5 10.0 0.013 
 (+) 10 45.1 10.5  41.2 6.05  44.3 19.9  
Upper-limb (−) 955 48.9 10.3 0.050 49.5 9.74 <0.001 52.4 10.0 0.365 
 (+) 17 43.5 7.68  40.4 7.23  50.2 14.0  
Neck-shoulder (−) 898 49.1 10.2 <0.001 49.8 9.59 <0.001 52.5 9.87 0.195 
 (+) 70 44.0 10.8  43.1 9.70  50.9 13.0  
Lumbar (−) 905 49.4 9.85 <0.001 49.8 9.66 <0.001 52.4 10.0 0.653 
 (+) 61 40.9 12.4  43.4 9.31  51.9 12.5  
Knee (−) 940 49.1 10.0 <0.001 49.6 9.68 <0.001 52.3 10.0 0.195 
 (+) 30 39.2 12.5  42.2 10.2  54.7 13.0  
Foot (−) 939 49.0 10.2 <0.001 49.5 9.77 <0.01 52.4 9.94 0.396 
 (+) 31 40.7 11.0  44.9 8.69  50.9 14.9  
Others (−) 946 49.1 10.0 <0.001 49.6 9.66 <0.001 52.4 10.0 0.835 
 (+) 24 35.8 13.2  40.8 9.90  52.8 14.6  
SD: Standard Deviation; PCS: Physical Component Summary; MCS: Mental Component Summary; RCS: Role Component Summary; Others include 
chest, abdomen, hip, and back pain. ANCOVA was performed with adjustment for age and gender. 
 
Table 5. Multiple regression analysis of the relations between 3 component summary score and the pain site, gender. 
Criterion Variables B SE Beta  Standardized t P 





PCS (Constant) 61.02 2.25  27.18 <0.001 56.6 65.4 
 Others −11.29 2.03 −0.172 −5.57 <0.001 −15.3 −7.31 
 Lumbar −5.55 1.35 −0.132 −4.12 <0.001 −8.19 −2.90 
 Age −0.21 0.04 −0.154 −5.03 <0.001 −0.285 −0.125 
 Knee −6.78 1.86 −0.115 −3.65 <0.001 −10.4 −3.13 
 Foot −3.78 1.86 −0.065 −2.03 0.042 −7.44 −0.133 
MCS (Constant) 34.94 2.15  16.28 <0.001 30.7 39.2 
 Age 0.28 0.04 0.221 7.23 <0.001 0.205 0.357 
 Neck-shoulder −3.60 1.24 −0.096 −2.90 <0.01 −6.03 −1.17 
 Others −6.72 1.93 −0.108 −3.48 <0.001 −10.5 −2.93 
 Knee −6.11 1.74 −0.109 −3.51 <0.001 −9.52 −2.70 
 Upper-limb −7.22 2.30 −0.098 −3.14 <0.01 −11.7 −2.71 
 Lumbar −3.06 1.33 −0.077 −2.29 0.022 −5.68 −0.440 
RCS (Constant) 52.47 0.33  159.78 <0.001 51.8 53.1 
 Head −8.16 3.22 −0.082 −2.54 0.011 −14.5 −1.84 
PCS; R2 = 0.117, Adjusted R2 = 0.112; MCS; R2 = 0.119, Adjusted R2 = 0.113; RCS; R2 = 0.07, Adjusted R2 = 0.006; SE: Standard Error; PCS: 
Physical Component Summary; MCS: Mental Component Summary; RCS: Role Component Summary; Others include chest, abdomen, hip, and back 
pain. Multiple linear regression analysis was performed with a forward stepwise approach, including gender, age, and site of pain. 




In previous reports, prevalence rates of CP have varied [6]-[8], possibly due to bias related to different collection 
rates of questionnaires and selection bias. Participants in other studies were selected from internet volunteers 
and mail survey panels, so there were relatively low response rates, such as 72.2% for internet research [6] and 
55% for the mail survey [7] In addition, there have been few investigations into the prevalence of CP or the rela-
tionship between CP and HRQoL involving an epidemiological survey of all residents in a region. One of our 
aim was to clarify more accurate prevalence rate of CP and its relationship with and HRQoL. In this study, we 
defined CP as an NRS score of more than 5 so that we could perform comparison with previous studies. Our re-
sults indicated that the prevalence of CP was 15.3% among men and 15.1% among women. In addition, CP was 
more prevalent in the lumbar and neck/shoulder regions of our working age subjects. According to previous 
population-based surveys, the prevalence of CP was 19% in Europe and 13.6% in Japan [5] [6]. Our survey me-
thod agreed with the previous population-based finding that the prevalence of CP is about 15.0%, suggesting 
that our data were reliable. 
The prevalence of chronic headache differs depending on the gender, age and geographic region [23]. Take-
shima et al. examined the prevalence of headache in Daisen, a rural community in Japan, and reported that the 
prevalence of migraine was 2.3% in men and 9.1% in women [24]. An epidemiologic study performed by Sakai 
et al. revealed that the prevalence of migraine during the past year was 8.4% [25]. However, these studies as-
sessed migraine and not chronic headache. Our study showed that the prevalence of chronic headache was 0.899% 
among men and 1.43% among women, suggest that there was no significant gender difference. Unfortunately, 
few data on chronic headache are available in Japan, different from migraine. Previous research has been per-
formed in Spain [26], the Netherlands [27], the United States [28], and Korea [29], showing that the prevalence 
of chronic headache was 1.8% - 4.2%, with the lowest rate of 1.8% in Korea. These studies have suggested that 
the prevalence of chronic headache is lower in Asia than in western countries. Our results for a rural Japanese 
population support the concept that there is a lower prevalence of CP in Asia compared with Europe. 
Suzukamo demonstrated that, among the 3 components of SF-36, RCS is strongly associated with the RP, SF, 
and RE subscales in specific social activities such as the number of times work, school, or housework missed for 
health-related reasons, and that this model was more appropriate than a two-component model for Japan and 
other Asian countries [22] [30]. It has been reported that social activities have independent health benefits [31], 
while the WHO has claimed that activity and participation involve factor structures in the international classifi-
cation of functioning, disability, and health (ICF), in the same way as body function and structure [32]. 
We found that the influence of chronic headache on MCS and RCS, and not on PCS, whereas of musculoske-
letal pain had a significant influence on PCS and MCS. Taken together with our identification of significant dif-
ference in PCS and MCS, but not in RCS between age categories, it seems that RCS is independent and distinct 
from either PCS or MCS in Japan. 
It is noteworthy that our study demonstrated a relationship between chronic headache and RCS, because this 
has not been reported previously. Sakai et al. examined chronic tension headache and showed impairment of 
daily activities in 40.5% by this type of headache [33]. Bigal et al. reported that the impact of chronic headache 
is significantly greater than that of migraine, e.g. with regard to missing work and reducing productivity [11] 
[12]. In addition, Wang found lower SF-36 scores than normal in outpatients with headache and a lower score in 
those with chronic headache rather than migraine [34]. However, the influence of pain at other sites on HRQoL 
was not considered in previous studies. Holroyd et al. demonstrated that HRQoL scores were lower in chronic 
tension headache than in healthy controls, along with lower scores for back pain and arthritis [35]. In addition to 
our finding of a lower HRQoL in the present study population with chronic headache, we analyzed the effect of 
chronic headache after adjusting for pain at other sites which may have an impact on HRQoL. Therefore, our 
finding of a relationship between headache and RCS, which is supported by the above methods of analysis, pro-
vides convincing evidence for involvement of chronic headache in HRQoL (probably a different etiology from 
that at the other sites). 
5. Conclusion 
In conclusion, we demonstrated a relationship between RCS and chronic headache, but no relationships between 
RCS and musculoskeletal pain, while there was relationship between musculoskeletal pain and PCS or MCS. It 
suggested that RCS was independent component distinct from PCS and MCS in Japan. These results also sug-
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gested the influence of headache on HRQoL, probably because it had a different etiology from pain at other 
sites. 
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and high return rate of questionnaires. 
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